NCT04295044

Brief Summary

Our prior studies demonstrated that dehydration was a predictor for poor outcome in stroke and Blood urea nitrogen/Cr ratio-based saline hydration therapy in patients with acute ischemic stroke may increase the rate of favorable clinical outcome with functional independence at 3 months after stroke. However, dehydration is likely to be only a part of representation in poor nutrition status and physical fragility for a stroke patient. Our prior study found that acute stroke patients admitted to neurological intensive care unit with low urinary creatinine excretion rate (CER), a marker of muscle mass, was associated with poor outcome at 6 months after stroke. An animal study suggested inadequate food and water intake determine mortality following stroke in mice and nutritional support reduced the 14-day mortality rate from 59% to 15%. A study also showed that high protein intake was associated with a better outcome in previous cardiovascular events. We will calculate CER based on published equation. Based on our prior study, acute stroke patients with their CER\<1500 mg/day will be enrolled. A randomized controlled trial will be conducted and patients will be randomly assigned to high protein diet or normal protein diet for at least 2 weeks. We plan to enroll 300 patients, with 150 patients in ach group, during 3-year study period. We will consult dietitians for arrangement of their diet. We assume that patients receiving high protein diet will have higher opportunity to walk independently (modified Rankin Scale 0-1) at 3 month after stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Dec 2017

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2017

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

March 3, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 4, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

March 30, 2023

Status Verified

March 1, 2023

Enrollment Period

3 years

First QC Date

March 3, 2020

Last Update Submit

March 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • modified Rankin Scale 0-1

    No significant disability

    3 months

Secondary Outcomes (1)

  • modified Rankin Scale 0-2

    3 months

Study Arms (2)

High protein diet

EXPERIMENTAL

received high protein diet, prescribed by dietitian

Dietary Supplement: high protein diet

Normal protein diet

ACTIVE COMPARATOR

received normal protein diet, prescribed by dietitian

Dietary Supplement: normal protein diet

Interventions

high protein dietDIETARY_SUPPLEMENT

receive 1.8g protein/kg

High protein diet
normal protein dietDIETARY_SUPPLEMENT

receive 1g protein/kg

Normal protein diet

Eligibility Criteria

Age20 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • acute ischemic stroke during hospitalization
  • eGFR \>30
  • urine albumin creatinine ratio \< 30 mg/g
  • urinary creatinine excretion rate (CER) \< 1500g/day

You may not qualify if:

  • chronic kidney disease stage 4 or 5 (i.e. eGFR \< 30)
  • proteinuria (protein 1+ or more in urine routine)
  • known impairment of functional status (mRS ≥ 2) prior to the index stroke
  • refuse to participate in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital, Chiayi Branch

Chiayi City, 613, Taiwan

Location

MeSH Terms

Conditions

Ischemic StrokeMuscular Atrophy

Interventions

Diet, High-Protein

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeuromuscular ManifestationsNeurologic ManifestationsAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2020

First Posted

March 4, 2020

Study Start

December 15, 2017

Primary Completion

December 31, 2020

Study Completion

March 31, 2021

Last Updated

March 30, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations